Page last updated: 2024-08-22

cladribine and Skin Neoplasms

cladribine has been researched along with Skin Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (60.00)18.2507
2000's2 (20.00)29.6817
2010's1 (10.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Lallas, A; Papadopoulou, A; Papazisis, G; Rigas, A; Stamatellos, VP; Stamoula, E1
Ergene, U; Işisağ, A; Ozbalcı, D1
Biernat, W; Jeziorski, A; Krykowski, E; Robak, E; Robak, T1
Bosly, A; Brousset, P; Delannoy, A; Pris, J; Riga-Huguet, F; Schlaifer, D1
Hurria, A; Kuzel, TM; Rademaker, AW; Roenigk, HH; Rosen, ST; Samuelson, E; Tallman, MS1
Piro, LD1
Kong, LR; Kuzel, TM; Rademaker, AW; Roenigk, HH; Rosen, ST; Samuelson, E; Tallman, MS1
Hönigsmann, H; Knobler, RM; Schwarzmeier, J; Trautinger, F1
Bouwhuis, SA; el-Azhary, RA; Gibson, LE; Habermann, TM; McEvoy, MT; Pittelkow, MR; Witzig, TE1
Beutler, E; Carrera, CJ; Carson, DA; Piro, LD; Saven, A1

Reviews

1 review(s) available for cladribine and Skin Neoplasms

ArticleYear
Cladribine in the treatment of low-grade non-Hodgkin's lymphoma.
    Seminars in hematology, 1996, Volume: 33, Issue:1 Suppl 1

    Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Skin Neoplasms; Waldenstrom Macroglobulinemia

1996

Trials

3 trial(s) available for cladribine and Skin Neoplasms

ArticleYear
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma.
    Blood, 1996, Feb-01, Volume: 87, Issue:3

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Marrow Diseases; Cladribine; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Opportunistic Infections; Sezary Syndrome; Skin Neoplasms; Treatment Outcome

1996
2-Chlorodeoxyadenosine in cutaneous T-cell lymphoproliferative disorders.
    Leukemia & lymphoma, 1997, Volume: 26, Issue:1-2

    Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoproliferative Disorders; Male; Middle Aged; Prognosis; Skin Neoplasms; Survival Rate

1997
Low-dose 2-chlorodeoxyadenosine for the treatment of mycosis fungoides.
    Archives of dermatology, 1999, Volume: 135, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Skin Neoplasms

1999

Other Studies

6 other study(ies) available for cladribine and Skin Neoplasms

ArticleYear
S1P receptor modulators in Multiple Sclerosis: Detecting a potential skin cancer safety signal.
    Multiple sclerosis and related disorders, 2022, Volume: 59

    Topics: Cladribine; Humans; Immunosuppressive Agents; Multiple Sclerosis; Skin Neoplasms; Sphingosine 1 Phosphate Receptor Modulators

2022
Hairy Cell Leukemia and cutaneous involvement.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2012, Volume: 46, Issue:2

    Topics: Antigens, CD; Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Male; Skin Neoplasms

2012
Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Carcinoma, Merkel Cell; Cladribine; Female; Humans; Immunosuppressive Agents; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Metastasis; Middle Aged; Remission Induction; Rituximab; Skin Neoplasms; Treatment Outcome

2005
Secondary neoplasms in two patients treated with purine analogues.
    Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:4

    Topics: Acute Disease; Aged; Cladribine; Female; Humans; Immunocompromised Host; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melanoma; Neoplasms, Second Primary; Skin Neoplasms; Vidarabine; Waldenstrom Macroglobulinemia

1994
Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.
    International journal of dermatology, 2002, Volume: 41, Issue:6

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Humans; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Retrospective Studies; Sezary Syndrome; Skin Neoplasms; Survival Rate

2002
2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.
    Blood, 1992, Aug-01, Volume: 80, Issue:3

    Topics: 2-Chloroadenosine; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Agents; Cladribine; Deoxyadenosines; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Skin Neoplasms; Time Factors

1992